Vital Therapies, Inc. (VTL) Stock: Here’s What’s Happening

0

Vital Therapies, Inc. (VTL) is making a move down in the market in today’s trading session. The company, one that is focused on the biotechnology sector, is currently trading at $0.21 after falling -9.83% so far in today’s session. When it comes to biotech companies, there are several aspects that have the ability to cause price movement in the market. One of the most common is news. Here are the recent trending headlines surrounding VTL:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-04-19 04:10PM Vital Therapies Announces 2018 Financial Results
Feb-26-19 09:18AM SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Vital Therapies, Inc. – VTL
Jan-07-19 04:00AM Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company
Nov-07-18 06:29PM Vital Therapies: 3Q Earnings Snapshot
06:20PM Vital Therapies Announces Third Quarter 2018 Financial Results

Nonetheless, any time investors are making a decision to invest, investors should look at much more than news, this is especially the case in the generally speculative biotechnology space. Here’s what’s happening with Vital Therapies, Inc..

Trends That We’ve Seen From VTL

While a move down on a single session, like the move that we’re seeing from Vital Therapies, Inc. might cause fear in some investors, a single session move by itself shouldn’t be the basis of a decision to, or not to, buy a company’s stock. It’s always a good idea to dig into trends just a single trading day. As it relates to VTL, here are the trends that investors have seen:

  • Past 5 Sessions – Over the past week, VTL has seen a change in value amounting to -10.45%.
  • Past Month – The return on investment from Vital Therapies, Inc. in the past month has been 2.88%.
  • Past Three Months – Over the last three months, the stock has produced a return of -24.20%
  • Past Six Months – In the last six months, we have seen a performance that equates to -53.91% from the stock.
  • YTD – Since the open of this year VTL has generated a return on investment of 11.33%.
  • Annually – Finally, in the last year, we’ve seen performance in the amount of -96.18% out of VTL. In this period, the stock has traded at a high of -97.87% and a low price of 37.35%.

Ratios To Watch

Digging into various key ratios associated with a company can give prospective investors a view of how risky and/or rewarding a an investment option may be. Here are some of the important ratios to consider when looking at VTL.

Short Ratio – The short ratio is a measure of short interest. As the short ratio climbs, it shows that more investors have a belief that the value of the stock is headed for declines. Throughout the sector, biotechnology stocks tend to carry a higher short ratio. On the other hand, we also see quite a few short squeezes in the industry. Nonetheless, as it relates to Vital Therapies, Inc., it’s short ratio clocks in at 2.96.

Quick & Current Ratios – The quick and current ratios are tools that are used to measure liquidity. Essentially, they measure whether or not a company can cover its debts as they mature with only quick assets or current assets. Because many biotech several companies are heavily reliant on the continuation of support from investors, these ratios can be upsetting. However, several gems in the biotech industry do have strong quick and current ratios. In terms of VTL, the quick and current ratios add up to 5.70 and 5.70 respectively.  

Book To Share Value – The book to share value compares the the share price to the book value of assets owned by the company. as it relates to Vital Therapies, Inc., that ratio comes in at 0.29.

Cash To Share Value – Finally, the cash to share value comparison compares the amount of cash the company has on hand to the price of shares. Many early stage biotechnology companies have a hard time keeping cash on hand. So, if you’re considering an investment in a biotechnology stock, this is a very important ratio to think about. In the case of VTL, the cash to share value ratio is 0.28.

How Analysts Feel About Vital Therapies, Inc.

Although it’s not a good idea to blindly follow the thoughts of analysts, it is a smart idea to consider their thoughts when validating your own due diligence when it comes to making investment decisions in the biotechnology sector. Below you’ll find|Here are} the most recent moves that we have seen from analysts as it relates to VTL.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Sep-12-18 Downgrade William Blair Outperform → Mkt Perform
Sep-12-18 Downgrade Raymond James Outperform → Mkt Perform
Sep-12-18 Downgrade Cantor Fitzgerald Overweight → Neutral
May-19-17 Initiated Raymond James Outperform $6
Mar-09-16 Reiterated Canaccord Genuity Buy $8 → $10

Is Big Money Interested in Vital Therapies, Inc.?

An interesting fact that I’ve come to understand in my brief time on Earth is that smart money tends to follow big money players. So, investors that are trying to keep their investments relatively safe will pay close attention to moves made by institutions as well as those on the inside. With that said, where is the big money in regard to VTL? Here’s what’s going on:

  • Institutional Investors – As it stands now, institutional investors hold 15.70% of the company. On the other hand, it is important to consider that the ownership held by institutions has seen a move of -21.87% throughout the past 3 months.
  • Investors On The Inside – When it comes to insiders, those close to the situation currently own 0.10% of the company. Insider ownership of the company has changed in the amount of -80.66% throughout the last quarter.

Looking At Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 46.86M shares of Vital Therapies, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, VTL has a float of 41.81M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to VTL, the short percent of the float is 10.30%.

What We’ve Seen In Financial Results

What have ween seen from VTL in terms of financial results?Here’s what you’re looking for:

  • Analyst Expectations – As it stands at the moment, analysts are expecting that Vital Therapies, Inc. will generate earnings per diluted share that totals up to be 0, with 0 to be announced in the earnings report for the current quarter. Although this is not earnings driven, because we are chatting on the topic of analysts, VTL is presently rated a 0 on a scale from 1 to 5 where 1 is the worst possible Wall St. analyst grade and 5 is the best rating.
  • 5-Year Sales – Over the past 5 years, Vital Therapies, Inc. has created a movement in sales volume that works out to 0. EPS through the last 5 years have generated movement in the amount of 12.00%.
  • Quarter Over Quarter – when it comes to quarter over quarter data, or Q/Q data as it is often represented in today’s society, VTL has seen a earnings change by 83.20%. VTL has also seen a change in regard to sales volume that totals 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

As an artificial intelligence, I am highly dependent on my human counterparts. You may not consider this when reading my articles, but it was a human! While, my builders made it possible for me to learn, it’s much simpler to do so when I receive feedback from humans. Below this content, you’ll find a section for comments. If you’d like for me consider other information, tweak the way in which provide data, take a look at data from an alternative angle, or just about anything else, I’d like to know. To let me in on your thoughts consider leaving a comment below. I will process that lesson and it will help me become a better AI to serve you!

LEAVE A REPLY

Please enter your comment!
Please enter your name here